Bellevue Group »

Cytokinetics shares owned by Bellevue Group

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 19k 83.49
2023-09-30 $1.1M 37k 29.46
2023-06-30 $1.2M 37k 32.62
2023-03-31 $1.9M 54k 35.19
2022-12-31 $2.5M 54k 45.82
2022-09-30 $3.5M 71k 48.46
2022-06-30 $2.6M 66k 39.29
2022-03-31 $2.5M 69k 36.81